Mylan's generic of cholesterol drug Crestor gets tentative FDA nod

07/10/2013 | Drug Store News

Mylan received tentative FDA approval for its cholesterol-lowering treatment rosuvastatin calcium. The treatment, available in 40 mg, 20 mg, 10 mg and 5 mg tablets, is a generic copy of AstraZeneca's Crestor.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA